General MedicationsINJECTIONGeneric
PROLIXIN DECANOATE
FLUPHENAZINE DECANOATE
Standard Dose
25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Key Takeaways
- Primary indication: Marketing status: Discontinued
- Approval overview PROLIXIN DECANOATE is listed in Drugs@FDA under application 016727 (NDA).
- Marketing status: Discontinued Active ingredient FLUPHENAZINE DECANOATE Form and strength INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2009-03-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROLIXIN DECANOATE is listed in Drugs@FDA under application 016727 (NDA). Marketing status: Discontinued Active ingredient FLUPHENAZINE DECANOATE Form and strength INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.